Burrell Terry-Ann

CIK 00017864843 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001786484

Recent Transactions

50 trades

Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-01+1,843→ 71,254 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-03+26,193→ 26,193 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-03+13,097→ 69,411 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2024-04-26+25,000→ 25,000 total
Award
Beam Therapeutics Inc.$BEAM
Common Stock
2024-04-26+12,500→ 82,637 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-01+1,467→ 56,314 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2024-04-01$32.12/sh−5,446→ 70,137 total
Award
Beam Therapeutics Inc.$BEAM
Common Stock
2024-03-31+27,500→ 75,583 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2024-01-31$24.40/sh+55,000→ 55,000 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-13$12.59/sh−8,275→ 54,847 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-12$13.18/sh−3,195→ 66,279 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-12$11.25/sh−24,302→ 147,545 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-12$14.08/sh−3,157→ 63,122 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-12$12.15/sh−78,071→ 69,474 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-16+12,612→ 171,847 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-16+25,224→ 25,224 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-04-04$29.09/sh−2,186→ 47,117 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-04-03$30.31/sh−2,454→ 49,303 total
Award
Beam Therapeutics Inc.$BEAM
Common Stock
2023-03-31+20,000→ 51,277 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-31+20,000→ 20,000 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-31+40,000→ 40,000 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-27−36,152→ 185,565 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-27$13.68/sh+36,152→ 67,429 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-27$45.08/sh−36,152→ 31,277 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-26$13.68/sh+1,102→ 32,379 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-26$45.16/sh−1,102→ 31,277 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-26−1,102→ 221,717 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-24−14,810→ 222,819 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-24$13.68/sh+14,810→ 46,087 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-24$45.01/sh−14,810→ 31,277 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-23−5,426→ 237,629 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-23$13.68/sh+5,426→ 36,703 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-23$45.02/sh−5,426→ 31,277 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-01-18−39,886→ 243,055 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-18$45.14/sh−47,195→ 31,277 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Common Stock
2023-01-18$13.68/sh+39,886→ 78,472 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-01-03+1,821→ 159,235 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-10-03+1,265→ 157,414 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-07-01+1,631→ 156,149 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-06-14+18,145→ 154,518 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (right to buy)
2022-06-14+36,290→ 36,290 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-04-01+1,788→ 136,373 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2022-03-31$59.11/sh−1,787→ 38,278 total
Award
Beam Therapeutics Inc.$BEAM
Common Stock
2022-03-31+15,000→ 40,065 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2022-01-31+30,000→ 30,000 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-01-03+763→ 134,585 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-10-01+629→ 133,822 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-07-01+382→ 133,193 total
Exercise/Conversion
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2021-06-30−30,000→ 282,941 total
Sale
Beam Therapeutics Inc.$BEAM
Common Stock
2021-06-30$117.00/sh−15,000→ 39,809 total

Companies

Recent Filings

Address

C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov